Pérez, A. I. R., Pedrosa, M. A., Labandeira, C. M., Valenzuela, R., Quijano, A., Sanchez-Andrade, M., . . . Labandeira-García, J. L. (2023). AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY. Elsevier.
Citace podle Chicago (17th ed.)Pérez, Ana Isabel Rodríguez, María A. Pedrosa, Carmen M. Labandeira, Rita Valenzuela, Aloia Quijano, Mariña Sanchez-Andrade, Juan Antonio Suárez-Quintanilla, Jose Lanciego, a José Luis Labandeira-García. AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY. Elsevier, 2023.
Citace podle MLA (9th ed.)Pérez, Ana Isabel Rodríguez, et al. AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY. Elsevier, 2023.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..